Naloxegol: all 34 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced ConstipationCompletedNCT03523520Phase 4Results posted
- Ancillary Effects of Oral Naloxegol (Movantik)CompletedNCT03235739Phase 4Results posted
- Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerTerminatedNCT03087708Phase 2Results posted
- To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced ConstipationCompletedNCT03060512Phase 4Results posted
- Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered OpioidsTerminatedNCT02977286Phase 4Results posted
- Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery PatientsTerminatedNCT02946580Phase 4Results posted
- Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)TerminatedNCT02839889Phase 4Results posted
- Naloxegol in Cancer Opioid-Induced ConstipationTerminatedNCT02745353Phase 2Results posted
- A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and SolutionCompletedNCT02446171Phase 1Results posted
- A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced ConstipationCompletedNCT01395524Phase 3Results posted
- Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related PainTerminatedNCT01384292Phase 3Results posted
- Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced ConstipationCompletedNCT01336205Phase 3Results posted
- Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced ConstipationCompletedNCT01323790Phase 3Results posted
- Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced ConstipationCompletedNCT01309841Phase 3Results posted
- A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)CompletedNCT00600119Phase 2Results posted
- Colonic Motor Patterns in Healthy VolunteersCompletedNCT05770960Phase 4
- The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtientsSuspendedNCT05008926Phase 3
- Effect of Naloxegol on Postoperative Ileus in Patients Undergoing Cardiac SurgeryCompletedNCT04433390Phase 3
- Evaluation of Naloxegol in the Prevention of POI After CystectomyWithdrawnNCT04219046Phase 2
- Naloxegol and Opioid-induced ConstipationStatus unknownNCT03316859Phase 2/3
- Naloxegol for Opioid-Related GastroparesisWithdrawnNCT03036891Phase 2
- Movantik for Opioid-Related Esophageal DisordersTerminatedNCT02998606Phase 2
- The Effect of Naloxegol on Refractory Constipation in the Intensive Care UnitWithdrawnNCT02705378Phase 3
- Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC PatientsCompletedNCT02099591Phase 1
- Open Label, Healthy Volunteers, Bioequivalence Study With NaloxegolCompletedNCT01623609Phase 1
- Study in Healthy Volunteers to Investigate the Effects of Diltiazem on the Pharmacokinetics of NaloxegolCompletedNCT01594619Phase 1
- Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118CompletedNCT01533870Phase 1
- Study in Healthy Volunteers to Investigate the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118CompletedNCT01520896Phase 1
- Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic FunctionCompletedNCT01392807Phase 1
- Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal FunctionCompletedNCT01372826Phase 1
- Assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy SubjectsCompletedNCT01365000Phase 1
- Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] NKTR-118CompletedNCT01348724Phase 1
- A Placebo-controlled Four Way Crossover Study to Asses the Effect of a Single Oral Dose of NKTR-118 on QTc Interval in Healthy Male SubjectsCompletedNCT01325415Phase 1
- Single and Multiple Ascending Dose Study for NKTR-118 and Cross-over Study to Investigate the Effect of Food for NKTR-118 in Japanese Healthy SubjectsCompletedNCT01318655Phase 1